Company: WHWK
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015269
Chunk: 283

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 283
---
 in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

148

NameTitleDate/s/ David J. LennonChief Executive Officer and President and Director(Principal Executive Officer)March 27, 2025David J. Lennon, Ph.D./s/ Scott GiacobelloChief Financial Officer(Principal Financial and Accounting Officer)March 27, 2025Scott Giacobello/s/ Caley CasteleinChairmanMarch 27, 2025Caley Castelein, M.D./s/ Behzad AghazadehDirectorMarch 27, 2025Behzad Aghazadeh, Ph.D./s/ Anupam DalalDirectorMarch 27, 2025Anupam Dalal, M.D./s/ Neil DesaiDirectorMarch 27, 2025Neil Desai, Ph.D./s/ Karin HehenbergerDirectorMarch 27, 2025Karin Hehenberger, M.D., Ph.D./s/ Mohammad HirmandDirectorMarch 27, 2025Mohammad Hirmand, M.D./s/ Richard MarounDirectorMarch 27, 2025Richard Maroun, J.D./s/ Emma ReeveDirectorMarch 27, 2025Emma Reeve/s/ Baiteng Zhao, Ph.D.DirectorMarch 27, 2025Baiteng Zhao, Ph.D.

149